Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1985 | 12-1984 | 12-1983 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 192 | 703 | N/A |
| Receivables | 2 | 4 | N/A |
| Other current assets | 74 | 59 | 0 |
| TOTAL | $267 | $766 | $N/A |
| Non-Current Assets | |||
| PPE Net | 738 | 901 | N/A |
| Other Non-Current Assets | 9 | 20 | 0 |
| TOTAL | $747 | $921 | $N/A |
| Total Assets | $1,014 | $1,687 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 256 | 217 | 0 |
| TOTAL | $731 | $217 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $731 | $217 | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -6,018 | -4,745 | N/A |
| Other shareholders' equity | 9 | 8 | 0 |
| TOTAL | $283 | $1,471 | $N/A |
| Total Liabilities And Equity | $1,014 | $1,687 | $0 |